AFTD's newsletter emailed 6x/year for researchers that shares funding opportunities, plus research articles and updates.
Meet the Researcher: Indira García-Cordero, PhD
“Over the years, I have had the privilege of meeting and working with people living with FTD and their families. Their strength and resilience have inspired me and motivated me to focus my research on this area. Through my work, I hope to give something back by improving our understanding of the disease. I am…
FTD Research Spotlight – Collaboration for Future FTD Clinical Trials: the 2025 FTD Research Roundtable
This September marked the third annual FTD Research Roundtable hosted by AFTD. This event brings together diverse stakeholders, particularly industry partners, working towards addressing barriers to finding disease-modifying therapies for FTD. Each year is focused on a new topic. This year’s title was “outcome measures and statistical power in FTD clinical trials,” which are important…
Meet the Researcher: Carmela Tartaglia, MD, FRCPC
Dr. Tartaglia is a cognitive behavioral neurologist and Professor at the University of Toronto and the University Health Network. She is the Executive Director of the Toronto Dementia Research Alliance and runs a research program on dementias – with a particular focus on FTD. The ultimate goal of her work is to diagnose neurodegenerative disorders…
FTD Research Spotlight: Genetic FTD Trials Update – Approaching a Phase 3 Milestone
The FTD research landscape is on the verge of major developments. For the first time, a Phase 3 trial has been completed for a potentially disease-modifying treatment for a type of genetic FTD, with results expected in 2025. As we wait for these Phase 3 trial results, we are taking time to summarize current updates…
FTD Research Spotlight: A New Researcher Portal and Other Updates from the FTD Disorders Registry
It is a pivotal time for FTD clinical research. New therapies have advanced to phase 3 clinical trials. Treatments for FTD caused by variants in specific genes are closer than ever. Trials targeting sporadic FTD are also emerging, such as an ongoing trial on semantic variant primary progressive aphasia (svPPA) and an upcoming platform trial…
Meet the Researcher: Chiadi Onyike, MD, MHS
“The inspiration to focus my work on FTD care and research was my deep interest in understanding the cognitive and behavioral capacities that underpin human experience. FTD research has provided profound lessons about human agency, conduct, socialization, and language.” Dr. Onyike is a neuropsychiatrist specializing in FTD and young-onset dementias. He earned his medical degree…
Sign up to receive FTD Research Spotlight in your inbox six times a year!
